Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-25T08:33:03.178Z Has data issue: false hasContentIssue false
  • English
  • Français

¿Son las anomalías de los movimientos oculares indicadores de vulnerabilidad genética a la esquizofrenia?

Published online by Cambridge University Press:  12 May 2020

C. Boudet ,
M. L. Bocca ,
B. Chabot ,
P. Delamillieure ,
P. Brazo ,
P. Denise  and
S. Dollfus
C. Boudet
Affiliation:
Grupo de Imágenes Neurofuncionales (GIN), UMR 6194, CNRS/CEA/Universidad de Caen/Universidad París V, Centro Cyceron, boulevard H.-Becquerel, 14000Caen, Francia
M. L. Bocca
Affiliation:
Servicio de Exploraciones Funcionales, Centro Hospitalario y Universitario de Caen, 14033Caen cedex, Francia
B. Chabot
Affiliation:
Centro Esquirol, Centro Hospitalario y Universitario de Caen, 14033, Caen, Francia
P. Delamillieure
Affiliation:
Grupo de Imágenes Neurofuncionales (GIN), UMR 6194, CNRS/CEA/Universidad de Caen/Universidad París V, Centro Cyceron, boulevard H.-Becquerel, 14000Caen, Francia Centro Esquirol, Centro Hospitalario y Universitario de Caen, 14033, Caen, Francia
P. Brazo
Affiliation:
Grupo de Imágenes Neurofuncionales (GIN), UMR 6194, CNRS/CEA/Universidad de Caen/Universidad París V, Centro Cyceron, boulevard H.-Becquerel, 14000Caen, Francia Centro Esquirol, Centro Hospitalario y Universitario de Caen, 14033, Caen, Francia
P. Denise
Affiliation:
Servicio de Exploraciones Funcionales, Centro Hospitalario y Universitario de Caen, 14033Caen cedex, Francia
S. Dollfus
Affiliation:
Grupo de Imágenes Neurofuncionales (GIN), UMR 6194, CNRS/CEA/Universidad de Caen/Universidad París V, Centro Cyceron, boulevard H.-Becquerel, 14000Caen, Francia Centro Esquirol, Centro Hospitalario y Universitario de Caen, 14033, Caen, Francia
Get access

Resumen

De un cincuenta a un ochenta y cinco por ciento de los pacientes esquizofrénicos tiene deficiencias en los paradigmas de seguimiento ocular. Sin embargo, los resultados con respecto a los familiares son más discordantes. El propósito de este estudio era investigar si los trastornos de los movimientos oculares podrían ser un marcador de vulnerabilidad de la esquizofrenia. Métodos.- Se incluyó a 21 pacientes esquizofrénicos (DSM-IV), 31 familiares en primer grado de esos pacientes sin trastornos del espectro esquizofrénico y dos grupos de controles sanos emparejados por la edad y el sexo. Se utilizaron tres tareas oculomotoras (seguimiento, movimientos sacádicos reflejos y movimientos antisacádicos). Resultados.- Los pacientes tuvieron una ganancia media más baja (P = 0,035) durante el seguimiento que los controles, hicieron menos movimientos sacádicos guiados visualmente correctos (P < 0,001) y cometieron más errores en los movimientos antisacádicos (P= 0,002) que los controles. Por contraste, ninguna de las comparaciones entre los familiares y sus controles fue significativa. Conclusión.- Los pacientes esquizofrénicos eran deficientes en los paradigmas de seguimiento y movimientos antisacádicos. Sin embargo, no se observó ninguna de estas deficiencias en sus familiares en primer grado. Nuestros resultados indican que los parámetros de movimiento ocular examinados no se podían considerar como marcadores de vulnerabilidad para la esquizofrenia.

Keywords

EsquizofreniaFamiliaresMovimientos oculares de seguimientoMovimientos sacádicosMovimientos antisacádicosGenéticaEfecto de la edad
Type
Artículo original
Information
European Psychiatry (Ed. Española) , Volume 12 , Issue 8 , November 2005 , pp. 446 - 453
Copyright
Copyright © European Psychiatric Association 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

[1] American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: APA; 1994.Google Scholar
[2]Bahill, ATMcDonald, JD. Frequency limitations and optimal stop size for the two-point central difference denvative algorithm with applications to human eye movement data. IEEE Trans Biomed Eng 1983; 30(3):191-4.CrossRefGoogle Scholar
[3]Ban, TA. Drug in schizophrenia. Can Psychiatr Assoc J 1971; 16:473-85.CrossRefGoogle Scholar
[4]Blackwood, DHRSt Clair, DMMuir, WJDuffy, JC. Auditory and eye-tracking dysfunction in schizophrenic pedigrees. Arch Gen Psychiatry 1991; 48:899–909.CrossRefGoogle ScholarPubMed
[5]Calhns, MEIacono, WGCurtis, CE. Smooth pursuit and antisaccade performance evidence trait stability in schizophrenia patients and their relatives. Int J Psychophysiol 2003; 49(2): 139-46.Google Scholar
[6]Calkins, MEKatsanis, JHammer, MAIacono, WG. The misclassification of blinks as saccades: implications for investigations of eye movement dysfunction in schizophrenia. Psychophysiology 2001; 38:761-7.Google Scholar
[7]Chouinard, GRoss-Chouinard, AAnnable, LJones, BD. Extrapyramidal Symptom Rating Scale. Can J Neurol Sci 1980; 7:233.Google Scholar
[8]Clementz, BAMcDowell, JEZisook, S. Saccadic System functioning among schizophrenia patients and their first-degree biological relatives. J Abnorm Psychol 1994; 103(2):277-87.CrossRefGoogle ScholarPubMed
[9]Crawford, TJHaeger, BKennard, CReveley, MAHenderson, L. Saccadic abnormalities in psychotic patients. I. Neuroleptic-free psychotic patients. Psychol Med 1995; 25:461-71.CrossRefGoogle ScholarPubMed
[10]Crawford, TJSharma, TPuri, BKMurray, RMBerridge, DMLewis, SW. Saccadic eye movements in familias multiply affected with schizophrenia: the maudsley family study. Am J Psychiatry 1998; 155:1703-10.CrossRefGoogle Scholar
[11]Curtis, CECalkins, MEIacono, WG. Saccadic disinhibition in schizophrenia patients and their first-degree biological relatives. A parametric study of the effects of increasing inhibitory load. Exp Brain Res 2001; 137:228-36.Google ScholarPubMed
[12]Denise, PDarlot, CIgnatiew-Charles, PToupet, M. Unilateral peripheral semicircular canal lesion and off-vertical axis rotation. Acta Otolaryngol (Stockh) 1996; 116:361-7.Google ScholarPubMed
[13]Diefendorf, ARDodge, R. An experimental study of ocular reactions of the insare from photographic records. Brain 1908; 31:451-89.CrossRefGoogle Scholar
[14]Endicott, JSpitzer, RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-44.CrossRefGoogle Scholar
[15]Flechtner, K-MSteinacher, BSauer, RMackert, A. Smooth pursuit eye movements of patients with schizophrenia and affective disorder during clinical treatment. Eur Arch Psychiatry Clin Neurosci 2002; 252:49–53.CrossRefGoogle ScholarPubMed
[16]Foster, RNeuroleptic equivalence. Pharmacol J 1989; 243:431-2.Google Scholar
[17]Friedman, LJesberger, JAMeltzer, HY. Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia. Psychiatry Res 1991; 41:25–36.CrossRefGoogle Scholar
[18]Fukushima, JFukushima, KChiba, TTanaka, SYamashita, IKato, M. Disturbances of voluntary control of saccadic eye movements in schizophrenia patients. Biol Psychiatry 1988,23:670-7.CrossRefGoogle Scholar
[19]Fukushima, JFukushima, KMonta, NYamashita, I. Further analysis o f the control o f voluntary eye movements in schizophrenic patients. Biol Psychiatry 1990; 28:943-58.Google Scholar
[20]Fukushima, JMonta, NFukushima, KChiba, TTanaka, SYamashita, I. Voluntary control of saccadic eye movements in patients with schizophrenic and affective disorders. J Psychiatry Res 1990; 24:9–24.CrossRefGoogle ScholarPubMed
[21]Gooding, DC. Antisaccade task performance in questionnaire-identified schizotypes. Schizophr Res 1999; 35:157-66.CrossRefGoogle ScholarPubMed
[22]Green, JFKing, DJTrimble, KM. Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam. J Psychopharmacol 2000; 14(l):30-6.CrossRefGoogle ScholarPubMed
[23]Holzman, PSProctor, LRKHughes, DW. Eye-tracking patterns in schizophrenia. Science 1973; 181:179-81.CrossRefGoogle Scholar
[24]Holzman, PSProctor, LRLevy, DLYasillo, NJMeltzer, HYHurt, SW. Eye-tracking dysfunctions in schizophrenic patients and their relatives. Arch Gen Psychiatry 1974; 31:143-51.CrossRefGoogle ScholarPubMed
[25]Holzman, PSLevy, DLUhlenhuth, EHProctor, LRFreedman, DX. Smooth-pursuit eye movements, and diazepam, CPZ, and secobartital. Psychopharmacologia (Berl) 1975; 44: 111-5.CrossRefGoogle Scholar
[26]Hutton, SBCrawford, TJPuri, BKDuncan, LJChapman, MKennard, C, et al. Smooth pursuit and saccadic abnormalities in firstepisode schizophrenia. Psychol Med 1998; 28:685-92.CrossRefGoogle Scholar
[27]Karoumi, BVentre-Dominey, JDalery, J. Intéret de l’étude des antisaccades chez les schizophrenes. Ann Psychiatry 1996; 11 (4):238 43.Google Scholar
[28]Karoumi, BSaoud, Md’Amato, TRosenfeld, FDenise, PGutknecht, C, et al. Poor performance in smooth pursuit and antisaccadic eyemovement tasks in healthy siblings of patients with schizophrenia. Psychiatry Res 2001; 101:209-19.CrossRefGoogle Scholar
[29]Karson, CNGoldberg, TELeleszi, JRIncreased blink rafe in adolescent patients with psychosis. Psychiatr Res 1986; 17:195-8.CrossRefGoogle Scholar
[30]Kathmann, NHochrein, AUwer, RBondy, B. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry 2003; 160:696–702.CrossRefGoogle ScholarPubMed
[31]Kay, SRFiszbein, AOpler, LA. The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13(2):261 -76.CrossRefGoogle Scholar
[32]Keefe, RSESilverman, JMMohs, RCSiever, LJHarvey, PDFriedman, L, et al. Eye-tracking, attention, and schizotypal symptoms in noflpsychotic relatives of patients with schizophrenia. Arch Gen Psychiatry 1997; 54:169-76.CrossRefGoogle ScholarPubMed
[33]Kremen, WSTsuang, MTFaraone, SVLyons, MJ. Using vulnerability indicators to compare conceptual models of genetic heterogeneity in schizophrenia. J Nerv Ment Dis 1992; 180(3): 141-52.CrossRefGoogle Scholar
[34]Küfferle, BFriedmann, ATopitz, AFoldes, PAnderer, PKutzer, M, et al. Smooth pursuit eye movements in schizophrenia: Influences of neuroleptic treatment and the question of specificity. Psychopathology 1990; 23:106-14.CrossRefGoogle ScholarPubMed
[35]Larrison, ALFerrante, CFBriand, KASereno, AB. Schizotypal traits, attention and eye movements. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24:357-72.CrossRefGoogle ScholarPubMed
[36]Lee, KHWilliams, LM. Eye movement dysfunction as a biological marker of risk for schizophrenia. Aust New Zealand J Psychiatry 2000; 34(Supp 1): S91–S100.CrossRefGoogle ScholarPubMed
[37]Lee, KHWilliams, LMLoughland, CMDavidson, DJGordon, E. Syndromes o f schizophrenia and smooth-pursuit eye movement dysfunction. Psychiatry Res 2001; 101: 11–21.CrossRefGoogle Scholar
[38]Lencer, RMalchow, CPKrecker, KNolte, APinnow, MZimmerman, S, et al. Smooth pursuit performance in familias with multiple oecurrence of schizophrenia and nonpsychotic familias. Biol Psychiatry 1999; 45:694 703.CrossRefGoogle Scholar
[39]Lencer, RMalchow, CPTrillenberg-Krecker, KSchwinger, EArolt, V. Eye-tracking dysffinction (ETD) in familias with sporadic and familial schizophrenia. Biol Psychiatry 2000; 47:391–401.CrossRefGoogle Scholar
[40]Levy, DLHolzman, PSM atthysse, SMendell, NR. Eye-tracking dysfunchon and schizophrenia: a critical perspective. Schizophr Bull 1993; 19(3):461–535.CrossRefGoogle ScholarPubMed
[41]Litman, REHommer, DWRadant, AClem, TPickar, D. Quantitative effects of typical and atypical neuroleptics on smooth pursuit eyetracking in schizophrenia. Schizophr Res 1994; 12:107-20.CrossRefGoogle Scholar
[42]Litman, REFuller Torrey, EHommer, DWRadant, ARPickar, DWeinberger, DR. A quantitative analysis of smooth pursuit eyetracking in monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1997; 54:417-26.CrossRefGoogle Scholar
[43]Loranger, AWSartorius, NAndreoli, ABerger, PBuchheim, PChannabasavanna, SM, et al. The World Health Organization. The International Personality Disorder Examination. Alcohol, drug abuse, and Mental Health Administration, international pilot study of personality disorder. Arch Gen Psychiatry 1994; 51(3):215-24.Google ScholarPubMed
[44]Mackert, AWoyth, CFlechtner, K-MVolz, H-RIncreased blink rafe in drug-nalve acate schizophrenic patients. Biol Psychiatry 1990; 27:1197-202.CrossRefGoogle Scholar
[45]Munoz, DPBroughton, JRGoldring, JEArmstroog, IT. Age-related performance of human subjects on saccadic eye movement tasks. Exp Brain Res 1998; 121:391–400.CrossRefGoogle ScholarPubMed
[46]Nkam, IThibaut, FDenise, Pvan der Elst, ASégard, LBrazo, P, et al. Saccadic and smooth-pursuit eye movements in deficit and non-deficit schizophrenia. Schizophr Res 2001; 48:145-53.CrossRefGoogle ScholarPubMed
[47]O’Driscoll, GALenzenweger, MFHolzman, PS. Antisaccades and smooth pursuit eye-tracking and schizotypy. Arch Gen Psychiatry 1998:55:837-43.CrossRefGoogle ScholarPubMed
[48]Ross, DEThaker, GKBuchanan, RWLahti, ACMedoff, DBartko, JJ, et al. Association of abnormal pursuit eye movements with the deficit syndrome in schizophrenic patients. Am J Psychiatry 1996; 153:1158-65.Google ScholarPubMed
[49]Ross, RGHarris, JGOlincy, ARadant, AAdler, LEFreedman, R. Familial transmission of two independent saccadic abnormalities in schizophrenia. Schizophr Res 1998; 30:59–70.CrossRefGoogle Scholar
[50]Ross, RGOlincy, ARadant, AAdler, LECompagnon, NFnedman, R. The effects of age on a smooth pursuit tracking task in adults with schizophrenia and normal subjects. Biol Psychiatry 1999; 46:383-91.CrossRefGoogle ScholarPubMed
[51]Schwartz, BDO'Brien, BAEvans, WJSautter, FJWinstead, DK. Smooth pursuit eye movement differences between familial and nonfamilial schizophrenia. Schizophr Res 1995; 17:211-9.CrossRefGoogle Scholar
[52]Sereno, ABHolzman, PS. Antisaccades and smooth pursuit eye movements in schizophrenia. Biol Psychiatry 1995; 37(6):394 401.CrossRefGoogle Scholar
[53]Sharpe, JASylvester, TO. Effect of aging on horizontal smooth pursuit. Invest Ophthal Visual Sci 1978; 17(5):465-8.Google ScholarPubMed
[54]Sweeney, JAHaas, GLLi, SWeiden, PJ. Selective effects of antipsychotic medications on eye-tracking performance in schizophrenia. PsychiatryRes 1994; 54(2): 185-98.Google Scholar
[55]Thaker, GKKirkpatrick, BBuchanan, RWEllsberry, RLahti, ATamminga, C. Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacolo bull 1989; 25:491-7.Google Scholar
[56]Thaker, GKCassady, SAdami, HMoran, MRoss, DE. Eye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients. Am J Psychiatry 1996; 153(3):362-8.Google ScholarPubMed
[57]Thaker, GKRoss, DECassady, SL, Adami HM j Medoff DR, Sherr J. Saccadic eye movement abnormalities in relatives of patients with schizophrenia. Schizophr Res 2000; 45:235-44.CrossRefGoogle ScholarPubMed